Is posterior polymorphous corneal dystrophy typically bilateral, and what are the treatment options?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is PPCD Bilateral or Unilateral?

Posterior polymorphous corneal dystrophy (PPCD) is classically a bilateral disease, but unilateral presentation occurs and is particularly common in pediatric cases. 1

Laterality Patterns

The 2024 AAO guidelines explicitly state that "corneal dystrophies are typically bilateral" 1, and PPCD follows this pattern in most cases. The disease is inherited in an autosomal dominant fashion and affects both eyes 2.

However, important exceptions exist:

  • Pediatric presentations are frequently unilateral: In a 2022 pediatric series, 11 of 19 patients (58%) presented with unilateral PPCD 3
  • Unilateral cases present with anisometropic astigmatism: The affected eye consistently shows greater astigmatism (≥1.5 diopters difference) and lower endothelial cell counts 4
  • Risk of amblyopia in unilateral cases: Children with unilateral PPCD require aggressive amblyopia screening and treatment, as 7 of 27 affected eyes in one series had amblyopia at presentation 3

Clinical pitfall: Don't dismiss PPCD as a diagnosis simply because only one eye appears affected on examination. The contralateral eye may have subclinical disease or develop manifestations later.


Treatment Options for PPCD

Most patients with PPCD require only observation, as the disease is often asymptomatic; however, treatment becomes necessary when corneal edema, glaucoma, or amblyopia develop. 5

Treatment Algorithm by Disease Severity

Asymptomatic/Mild Disease (Most Common)

  • Observation only with regular monitoring of:
    • Intraocular pressure (IOP) - critical because glaucoma is a major complication 5
    • Endothelial cell counts via specular microscopy
    • Refractive error in children to detect anisometropia

Refractive Amblyopia (Pediatric Cases)

  • Corrective spectacles as first-line treatment 4
  • Occlusion therapy and/or atropine penalization for established amblyopia 4
  • Early intervention is critical - visual prognosis depends on lesion position, age at diagnosis, and early spectacle correction 4

Glaucoma Management

  • Medical management of elevated IOP is first-line
  • Filtering surgery may be required for refractory cases 2
  • Critical consideration: All patients with broad-based iridocorneal adhesions develop elevated IOP 2

Corneal Edema Requiring Surgery

Endothelial keratoplasty (EK) is now the preferred surgical approach over penetrating keratoplasty (PK) for PPCD with corneal edema. 1

Surgical Options in Order of Preference:

  1. DMEK (Descemet's Membrane Endothelial Keratoplasty)

    • Fastest visual recovery (2/3 stable by 3 months) 1
    • Minimal refractive shift (+0.24 to +0.32 D) 1
    • Lower rejection risk than PK
    • 42-48% endothelial cell loss at 5 years 1
  2. DSAEK (Descemet's Stripping Automated Endothelial Keratoplasty)

    • Induces hyperopic shift (+1.10 D) - plan IOL power accordingly if combined with cataract surgery 1
    • 53% endothelial cell loss at 5 years 1
  3. Penetrating Keratoplasty (PK) - reserved for cases unsuitable for EK

    • Major concern specific to PPCD: High failure rate (41% in one series) 2
    • Glaucoma caused 27% of all graft failures in PPCD patients 2
    • Retrocorneal membrane formation occurred in 18% of grafts, exclusively in eyes with preoperative iridocorneal adhesions 2
    • Disease recurrence: Abnormal host endothelial cells can overgrow the donor graft within 3.5 years 6

Key Surgical Considerations

The presence of slit lamp-visible iridocorneal adhesions is the most important prognostic factor for keratoplasty failure in PPCD. 2 These patients have:

  • Higher risk of retrocorneal membrane formation
  • Increased glaucoma risk
  • Poorer overall graft survival

Common pitfall: The epithelial-like endothelial cells characteristic of PPCD can proliferate and migrate across the trabecular meshwork and onto donor grafts, causing both glaucoma and graft failure 2, 6. This unique pathophysiology makes PPCD more challenging to manage surgically than other endothelial dystrophies like Fuchs.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.